Patent ID: 6432971
Filing Date: 2002-08-13
Classification: A61K,A61P

Abstract:
A method of preventing prostatic carcinoma in human males who do not have benign prostatic hyperplasia and who are asymptomatic for prostatic cancer, which comprises of daily administering a therapeutically effective amount of a compound of the formula: wherein:R1 is hydrogen, methyl or ethyl; R2 is monocyclic aryl containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and 1 or more halogen (Cl, F or Br) substituents; Râ€² is hydrogen or methyl; Râ€³ is hydrogen or &bgr;-methyl; Râ€²â€³ is hydrogen, &agr;-methyl or &bgr;-methyl.